Stay updated with breaking news from Applied Dna Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
06.09.2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, announced today that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (“ADCL”), has launched monkeypox ... Seite 1
- Post-Quarter Close Cash Balance of $16.8 Million Includes Proceeds from Upsized Public Offering and Warrant Exercises - - Company to Hold Conference Call and Webcast Today,... | August 11, 2022
10.08.2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that LineaRx, the Company’s majority-owned biotherapeutics subsidiary, has for the first time successfully administered and expressed ... Seite 1
08.08.2022 - Applied DNA Sciences, Inc., (NASDAQ: APDN) (the “Company” or “Applied DNA”), a leader in polymerase chain reaction ('PCR')-based technologies, today announced the closing of its previously announced public offering of 3,000,000 shares of its common ... Seite 1
Applied DNA Sciences (NASDAQ:APDN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Monday, Zacks.com reports. According to Zacks, “Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government […]